Nell'era farmaceutica dell'intelligenza artificiale, Canaan Technology consente a ogni pillola di "pensare"

In the past two decades, the Internet has swept across every corner of the world, reshaping every scene of people’s life, work, study and social interaction. “Internet +” has become a powerful engine to promote social development. Today, standing at the new outlet of the times, we clearly perceive that a more subversive force is rising — the “AI +” era is coming in big strides. From intelligent voice assistants accurately responding to daily needs to intelligent robots on industrial production lines that collaborate efficiently, AI is empowering all industries with unprecedented breadth and depth. It not only inherits the connectivity advantages of the Internet, but also gives everything a “smart brain”, opening a new chapter of intelligent, refined and humanized development.

Canaan Technology has deep technical accumulation and market position in the field of pharmaceutical equipment. With the advancement of intelligent manufacturing, the company has deepened its layout in multiple AI application fields such as intelligent logistics, robots, and smart pharmaceuticals. It has applied AI technology in many pharmaceutical companies’ EPC overall solutions to help pharmaceutical companies realize a new unmanned, intelligent and green pharmaceutical process.

Digital Twin: Real-time Dynamic Simulation System Reconstructs Production Intelligence

The digital twin platform independently developed by Canaan Technology realizes the deep integration of physical production lines and virtual models. The system realizes three core functions by collecting equipment operation data (such as temperature, pressure, speed, etc.) in real time and combining it with advanced AI algorithms:

Ø Fault prediction and self-healing: Based on historical data training machine learning models, potential risks such as tablet press bearing wear and coating parameter deviation can be identified in advance with an accuracy rate of more than 95%, and maintenance costs are reduced by 30%.

Ø Dynamic process optimization: By simulating the tableting process under different formulations and humidity conditions, the parameter combination is automatically adjusted to reduce the tablet hardness fluctuation range from ±5% to ±1.5%.

Ø Cross-link collaboration: Realize the linkage of digital models of raw material pretreatment, tableting, coating and other links to achieve optimal material balance and energy efficiency throughout the process.

Cost Revolution: Continuous Manufacturing Technology Subverts Traditional Production Model

Canaan Technology, relying on its advantages in the accumulation of solid dosage form production line technology for pharmaceutical equipment, has launched an intelligent batch production control platform. By integrating material unpacking and weighing equipment, High Shear Mixer, Fluid-bed Dryer, Blender and AGV logistics equipment, it has built a complete continuous granulation production line. The system adopts an AI-driven continuous manufacturing mode to achieve intelligent management of the entire process from batch production instructions to equipment operation parameter control.

Taking a sustained-release tablet project as an example, compared with the traditional batch process, Canaan Technology’s AI+ system has brought significant benefits:

The system uses real-time quality monitoring feedback closed-loop control to reduce waiting time for intermediate inspection and reduce overall production costs by 52%.

Forward-looking layout: Patent matrix builds technological moat

Canaan Technology has formed an AI technology ecosystem covering drug research and development to production, and built a “Data + Algorithm + Knowledge” trinity smart pharmaceutical solution, including three core modules: equipment predictive maintenance, real-time quality control, and global production optimization. Among them, in terms of quality control, a quality prediction network based on federated learning has been built, which mainly integrates various types of data and establishes a dynamic prediction model covering key quality attributes to predict drug quality. The company’s patents cover a variety of fields from material transmission, fluid-bed design, coating machine improvement to granulation and drying integration. Through these patents, Canaan Technology has not only improved the performance and efficiency of its products, but also established a leading position in the pharmaceutical equipment industry.

As a pioneer in the digital transformation of the pharmaceutical industry, Canaan Technology is leading the industry from traditional experience models to data intelligence-driven strategic changes by building AI-enabled smart pharmaceutical solutions. Based on the independent innovation technology system, the company has formed a full-chain digital capability matrix covering drug discovery, process development, intelligent production and quality control. This full-life cycle technology layout that runs through research and development to commercialization